AAAAAA
Results:
1-13
|
Results: 13
Authors:
PANTEL K
AHR A
Citation: K. Pantel et A. Ahr, IMMUNOCYTOCHEMICAL AND MOLECULAR STRATEGIES FOR THE DETECTION OF MICROMETASTASES IN PATIENTS WITH SOLID EPITHELIAL TUMORS - A REVIEW, Nuclear medicine communications, 19(6), 1998, pp. 521-527
Authors:
CAMINADA MC
AHR A
SCHARRER I
SCHARL A
KAUFMANN M
Citation: Mc. Caminada et al., ACUTE EXACERBATED LUPUS-ERYTHEMATOSUS - D IFFERENTIAL-DIAGNOSIS OF A HELLP-SYNDROME, Geburtshilfe und Frauenheilkunde, 58(4), 1998, pp. 225-227
Authors:
AHR A
ARNOLD G
GOHRING UJ
COSTA S
SCHARL A
GAUWERKY JFH
Citation: A. Ahr et al., CYTOLOGY OF ASCITIC FLUID IN A PATIENT WITH METASTASIZING MALIGNANT BRENNER TUMOR OF THE OVARY - A CASE-REPORT, Acta cytologica, 41(4), 1997, pp. 1299-1304
Authors:
AHR A
GOHRING UJ
SCHARL A
TITIUS BR
CROMBACH G
Citation: A. Ahr et al., CORRELATION BETWEEN THE EXPRESSION OF THE ESTROGEN-DEPENDED PS2-PROTEIN AND PROGNOSIS, Tumordiagnostik & Therapie, 17(6), 1996, pp. 182-187
Authors:
GOHRING UJ
SCHARL A
THELEN U
AHR A
CROMBACH G
TITIUS BR
Citation: Uj. Gohring et al., PROGNOSTIC VALUE OF CATHEPSIN-D IN BREAST-CANCER - COMPARISON OF IMMUNOHISTOCHEMICAL AND IMMUNORADIOMETRIC DETECTION METHODS, Journal of Clinical Pathology, 49(1), 1996, pp. 57-64
Authors:
GOHRING UJ
SCHARL A
AHR A
Citation: Uj. Gohring et al., IMMUNOHISTOCHEMICAL DETECTION OF RECEPTOR S, PROTEASES, TUMOR-SUPPRESSOR PROTEINS AND PROLIFERATING MARKERS AS PROGNOSTIC INDICATORS FOR PRIMARY BREAST-CANCER PATIENTS, Geburtshilfe und Frauenheilkunde, 56(4), 1996, pp. 177-183
Authors:
GOHRING UJ
AHR A
SCHARL A
WEISNER V
NEUHAUS W
CROMBACH G
HOLT JA
Citation: Uj. Gohring et al., IMMUNOHISTOCHEMICAL DETECTION OF EPIDERMAL GROWTH-FACTOR RECEPTOR LACKS PROGNOSTIC-SIGNIFICANCE FOR BREAST-CARCINOMA, Journal of the Society for Gynecologic Investigation, 2(4), 1995, pp. 653-659
Authors:
GOHRING UJ
SCHARL A
HECKEL C
AHR A
CROMBACH G
Citation: Uj. Gohring et al., P53 PROTEIN IN 204 PATIENTS WITH PRIMARY BREAST-CARCINOMA - IMMUNOHISTOCHEMICAL DETECTION AND CLINICAL-VALUE AS A PROGNOSTIC FACTOR, Archives of gynecology and obstetrics, 256(3), 1995, pp. 139-146
Authors:
GOHRING UJ
SCHARL A
THELEN U
AHR A
TITIUS BR
Citation: Uj. Gohring et al., PROGNOSTIC-SIGNIFICANCE OF IMMUNOHISTOCHE MICAL DETECTION OF UROKINASE PLASMINOGEN-ACTIVATOR IN PRIMARY BREAST CARCINOMAS, Der Pathologe, 16(6), 1995, pp. 398-403
Authors:
AHR A
SCHARL A
GOHRING UJ
CROMBACH G
STOFFL M
Citation: A. Ahr et al., IMMUNOHISTOCHEMICAL DEMONSTRATION OF THE PS2 PROTEIN USING PARAFFIN SECTIONS OF MAMMARY-CARCINOMA TISSUE - COMPARISON WITH THE RESULTS OF AN IMMUNORADIOMETRIC ASSAY, Der Pathologe, 16(4), 1995, pp. 278-284
Authors:
GOHRING UJ
SCHARL A
STOFFL M
AHR A
BECKER M
CROMBACH G
Citation: Uj. Gohring et al., DETECTION OF PROLIFERATING CELL NUCLEAR A NTIGEN (PCNA) IN PRIMARY BREAST-CARCINOMA - A PROLIFERATION MARKER AS A PROGNOSTIC FACTOR IN NODALPOSITIVE PATIENTS, Tumordiagnostik & Therapie, 15(5), 1994, pp. 171-175
Authors:
NEUHAUS W
LANIJ B
AHR A
BOLTE A
Citation: W. Neuhaus et al., PSYCHOLOGICAL ADJUSTMENT TO DISEASE IN BR EAST-CANCER PATIENTS, Geburtshilfe und Frauenheilkunde, 54(10), 1994, pp. 564-568
Authors:
NEUHAUS W
EIBACH HW
AHR A
BOLTE A
Citation: W. Neuhaus et al., PREMATURE RUPTURE OF THE FETAL MEMBRANE - PROBLEMS AND OBSTETRIC MANAGEMENT, Geburtshilfe und Frauenheilkunde, 53(12), 1993, pp. 843-848
Risultati:
1-13
|